Young-age prostate cancer

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Clinical Pathology

• Publication date

  2015-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jclinpath-2015-202993PMID 25837493
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian

  2015cited by this paper
• Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.

  2015cited by this paper
• Population‐based analysis of prostate‐specific antigen (PSA) screening in younger men (<55 years) in Australia

  2014cited by this paper
• HOXB13 G84E–related Familial Prostate Cancers: A Clinical, Histologic, and Molecular Survey

  2014cited by this paper
• Reducing Prostate Cancer Racial Disparity: Evidence for Aggressive Early Prostate Cancer PSA Testing of African American Men

  2014cited by this paper
• A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.

  2014cited by this paper
• Prostate cancer in young men: an important clinical entity

  2014cited by this paper
• TMPRSS2-ERG fusions are strongly linked to young patient age in low-grade prostate cancer.

  2014cited by this paper
• ERG expression is associated with increased risk of biochemical relapse following radical prostatectomy in early onset prostate cancer

  2014cited by this paper
• Genome-Wide Association Scan for Variants Associated with Early-Onset Prostate Cancer

  2014cited by this paper
• Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer.

  2013cited by this paper
• Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

  2013cited by this paper
• HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk

  2013cited by this paper
• Retracted: Many young men with prostate‐specific antigen (PSA) screen‐detected prostate cancers may be candidates for active surveillance

  2013cited by this paper
• Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer

  2013cited by this paper
• Early onset prostate cancer has a significant genetic component

  2012cited by this paper
• Germline mutations in HOXB13 and prostate-cancer risk.

  2012cited by this paper
• BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

  2011cited by this paper
• Prediction of significant prostate cancer diagnosed 20 to 30 years later with a single measure of prostate‐specific antigen at or before age 50

  2011cited by this paper
• An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis

  2011cited by this paper
• Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity.

  2010cited by this paper
• Screening and prostate-cancer mortality in a randomized European study.

  2009cited by this paper
• Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET

  2009cited by this paper
• Treatment and survival outcomes in young men diagnosed with prostate cancer

  2009cited by this paper
• Urology group: prostate screening should be offered beginning at age 40.

  2009cited by this paper
• Is prostate cancer more common and more aggressive in African men?

  2008cited by this paper
• Progression after radical prostatectomy for men in their thirties compared to older men

  2008cited by this paper
• Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype

  2008cited by this paper
• Baseline Prostate-Specific Antigen Level and Risk of Prostate Cancer and Prostate-Specific Mortality: Diagnosis Is Dependent on the Intensity of Investigation

  2008cited by this paper
• Segregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance

  2007cited by this paper
• PSA doubling time predicts the outcome after active surveillance in screening-detected prostate cancer: results from the European randomized study of screening for prostate cancer, Sweden section.

  2007cited by this paper
• Incidence of impalpable carcinoma of the prostate and of non‐malignant and precarcinomatous lesions in Greek male population: An autopsy study

  2006cited by this paper
• The prevalence of prostate carcinoma and its precursor in Hungary: an autopsy study.

  2005cited by this paper
• Prostate cancer epidemiology.

  2003cited by this paper
• Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.

  2003cited by this paper
• Prevalence of prostate cancer and prostatic intraepithelial neoplasia in Caucasian Mediterranean males: An autopsy study

  2003cited by this paper
• Empiric risk of prostate carcinoma for relatives of patients with prostate carcinoma

  2003cited by this paper
• Hereditary prostate cancer: clinical characteristics and survival.

  2002cited by this paper
• Prostate cancer in men age 50 years or younger: a review of the Department of Defense Center for Prostate Disease Research multicenter prostate cancer database.

  2000cited by this paper
• Should African‐American men be tested for prostate carcinoma at an earlier age than white men?

  1999cited by this paper
• BRCA2 mutation in Icelandic prostate cancer patients

  1997cited by this paper
• The predictive value of race as a clinical prognostic factor among patients with clinically localized prostate cancer: a multivariate analysis of positive surgical margins.

  1997cited by this paper
• Patient age as a prognostic factor in prostate cancer.

  1994cited by this paper
• The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients.

  1993cited by this paper
• Cancer of the prostate. Do younger men have a poorer survival rate?

  1984cited by this paper
• Carcinoma of prostate in men less than fifty years old. Data from American College of Surgeons' National Survey.

  1982cited by this paper
• Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France

  1977cited by this paper
• Prostatic adenocarcinoma occurring in men under 50 years of age

  1972cited by this paper
• [Cancer of the prostate].

  1962cited by this paper
• Cáncer

  1939cited by this paper

• Prostate Cancer, JAK/STAT3 Dysregulation, and Flavonoids: Is There a Possible Link?

  2026cites this paper
• Assessment of prostate cancer awareness and screening knowledge among men in Najran, Saudi Arabia: a cross-sectional study

  2025cites this paper
• Chest Pain as a Symptom of Early-Onset Metastatic Prostate Cancer: Exploring the Role of Screening

  2025cites this paper
• Survival and oncological outcomes for young men (≤ 55 years) undergoing radical prostatectomy for localized prostate cancer.

  2025cites this paper
• SIU-ICUD: Epidemiology of Prostate Cancer

  2025cites this paper
• Prostate Cancer Before 50: A Wake-Up Call

  2025cites this paper
• Interpretable machine learning approaches for predicting prostate cancer by using multiple heavy metal exposures based on the data from NHANES 2003-2018.

  2025cites this paper
• Exploring the causal relationship between CX3CL1 and prostate cancer prognosis using Mendelian randomization

  2025cites this paper
• Ubiquitin B, Ubiquitin C, and β-Catenin as Promising Diagnostic and Prognostic Tools in Prostate Cancer

  2024cites this paper
• Challenges in magnetic resonance imaging-based detection of clinically significant prostate cancer in young patients: two alternative approaches

  2024cites this paper
• Prognostic Nomogram Predicting Survival and Propensity Score Matching with Demographics and Comparative Analysis of Prostate Small Cell and Large Cell Neuroendocrine Carcinoma

  2024cites this paper
• Sociodemographic and clinicopathologic characteristics of patients treated with high dose rate prostate brachytherapy in Nigeria

  2024cites this paper
• Age and Gender Disparities in Cancer Biomarker Expression: Insights from a Population-Based Investigation in Mymensingh District of Bangladesh

  2024cites this paper
• Psychological wellbeing and coping strategies of unmarried men with prostate cancer in urban Ghana

  2024cites this paper
• Firefighting, per‐ and polyfluoroalkyl substances, and DNA methylation of genes associated with prostate cancer risk

  2024cites this paper
• An In-Depth Look Into the Epidemiological and Etiological Aspects of Prostate Cancer: A Literature Review

  2023cites this paper
• Computed tomographic characterization of urinary stones in patients with urolithiasis from Southeast Mexico

  2023influential citation
• Biochemical outcome after curative treatment for localized prostate cancer with external beam radiotherapy: a cross-sectional study

  2023cites this paper
• Biological and Clinical Implications of Early-Onset Cancers: A Unique Subtype.

  2023cites this paper
• The Prevalence of Prostate Cancer Among Young Men Below 55 Years of Age in Nigeria

  2023influential citation
• Immunological analysis of Interleukin-10 (IL-10), tumor necrosis factor-a (TNF-a), and Prostate-specific antigen (PSA) in benign and malignant prostate cancer.

  2023cites this paper
• Biochemical outcomes and toxicities in young men with prostate cancer after permanent iodine-125 seed implantation: Prospective cohort study in 6662 patients.

  2023cites this paper
• A young patient with prostatic carcinoma with testicular metastasis

  2022cites this paper
• Age- and Stage-Dependent Prostate Cancer Aggressiveness Associated with Differential Notch Signaling

  2022cites this paper
• Prostate cancers in men under the age of 50: about a series in Togo, Sub-Saharan Africa

  2022cites this paper
• Comparison of histopathological features, survival, and oncological outcome between patients under and above 55-year-old with prostate cancer who underwent radical prostatectomy

  2022cites this paper
• Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone‐binding globulin on prostate cancer

  2022cites this paper
• Liquid Biopsy in Diagnosis and Prognosis of Non-Metastatic Prostate Cancer

  2022cites this paper
• Understanding the Uptake and Challenges of Genetic Testing Guidelines for Prostate Cancer Patients.

  2022cites this paper
• Cáncer de próstata de inicio temprano. ¿Una nueva entidad?

  2021cites this paper
• Outcome of 177Lu-PSMA-617 Radioligand Therapy in Chemo-Refractory Patients with Metastatic Castration-Resistant Early-Onset Prostate Cancer

  2021cites this paper
• Prevalence and Demographic Characteristics of Prostate Cancer Patients in Colombia: data from the National Health Registry from 2015 to 2019

  2021cites this paper
• Clinicopathological and molecular characteristics of prostate cancer diagnosed in young men aged up to 45 years

  2020influential citation
• Cancer-related mortality in Peru: Trends from 2003 to 2016

  2020cites this paper
• microRNA Expression Profiling in Young Prostate Cancer Patients

  2020influential citation
• Survival outcomes of Asian younger men (< 55 years) undergoing radical prostatectomy: a review of prostate cancer database in a tertiary hospital in Singapore

  2020cites this paper
• Is There any Relationship between Age of Patients and Prostate Cancer Aggressiveness?

  2020cites this paper
• Clinicopathological characteristics of localized prostate cancer in younger men aged ≤ 50 years treated with radical prostatectomy in the PSA era: A systematic review and meta‐analysis

  2020cites this paper
• Identification of candidate miRNAs in early-onset and late-onset prostate cancer by network analysis

  2020cites this paper
• Impact of biopsy perineural invasion on younger prostate cancer patients after radical prostatectomy

  2020cites this paper
• The characteristics and spatial distributions of prostate cancer in autopsy specimens

  2020cites this paper
• Staging Characteristics of Prostatic Cancer Patients in Department of Urology Dr. Soetomo Surabaya

  2020cites this paper
• Pathological characteristics of prostate cancer occurring in younger men: a retrospective study of prostatectomy patients.

  2019cites this paper
• Biochemical outcomes and predictive factors by risk group after permanent iodine-125 seed implantation: Prospective cohort study in 2,316 patients.

  2019cites this paper
• The Prostate

  2019cites this paper
• Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer

  2019cites this paper
• Prostate cancer in young men: An emerging young adult and older adolescent challenge

  2019cites this paper
• Rare germline mutations in African American men diagnosed with early‐onset prostate cancer

  2018cites this paper
• Outcomes of men aged ≤50 years treated with radical prostatectomy: a retrospective analysis

  2018cites this paper
• 68Ga‐PSMA PET/CT Replacing Bone Scan in the Initial Staging of Skeletal Metastasis in Prostate Cancer: A Fait Accompli?

  2018cites this paper
• Outcomes for Young Men With Localized Intermediate-Risk Prostate Cancer: An Analysis of the NCDB.

  2018cites this paper
• Rôle du récepteur des androgènes dans les communications cellulaires au sein du cancer de la prostate

  2018cites this paper
• Prostate cancer susceptibility and growth linked to Y chromosome genes.

  2018cites this paper
• PSA Screening for Prostate Cancer in Men under the Age of 65: A Review of Current Practice

  2018influential citation
• Variant Histology and Clinicopathological Features of Prostate Cancer in Men Younger than 50 Years Treated with Radical Prostatectomy

  2017cites this paper
• Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer

  2017cites this paper
• Cancer of the Kidney, Bladder, and Prostate

  2017cites this paper
• Successful sperm extraction and live birth after radiation, androgen deprivation and surgical castration for treatment of metastatic prostate cancer

  2017cites this paper
• MicroRNA-27a-5p Regulation by Promoter Methylation and MYC Signaling in Prostate Carcinogenesis

  2017cites this paper
• Cancer Incidence, Survival, and Mortality Among Adolescents and Young Adults

  2017cites this paper
• Impact of FTO SNPs rs9930506 and rs9939609 in Prostate Cancer Severity in a Cohort of Puerto Rican Men.

  2017cites this paper
• Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer

  2017cites this paper
• Low-dose-rate prostate brachytherapy: 4-8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival.

  2017cites this paper
• Glucose Metabolism in High-Risk Prostate Cancer Patients throughout the Acute Disease Trajectory

  2016cites this paper
• Analyse d'une série de 1880 biopsies prostatiques réalisées au Centre Hospitalier Universitaire de Martinique de mars 2013 à mai 2016

  2016influential citation
• Chapter 2 Global Epidemiology of Prostate Cancer

  2016cites this paper
• Clinicopathological and Prognostic Factors in 106 Prostate Cancer Patients Aged ≤55 Years: A Single-Center Study in China

  2016cites this paper
• Familial prostate cancer.

  2016cites this paper
• Prostate cancer in men aged less than 50 years at diagnosis

  2016cites this paper
• Syndrome-Associated Tumors by Organ System

  2016cites this paper
• TRAF6, a key regulator of TGFβ-induced oncogenesis in prostate cancer

  2015cites this paper